Metabolic control of antifungal drug resistance

被引:24
|
作者
Robbins, Nicole [1 ]
Collins, Cathy [1 ]
Morhayim, Jess [1 ]
Cowen, Leah E. [1 ]
机构
[1] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
Antifungal drug resistance; Saccharomyces cerevisiae; Candida albicans; Azole; Hsp90; Calcineurin; Tor; Threonine; Nutrient signaling; Erg3; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CALCINEURIN; EVOLUTION; HSP90; GROWTH; PATHWAY; MECHANISMS;
D O I
10.1016/j.fgb.2009.07.004
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Fungi have evolved an elegant repertoire of mechanisms to survive the cellular stress exerted by antifungal drugs such as azoles, which inhibit ergosterol biosynthesis inducing cell membrane stress. The evolution and maintenance of diverse resistance phenotypes is contingent upon cellular circuitry regulated by the molecular chaperone Hsp90 and its client protein calcineurin. Here, we establish a novel role for nutrients and nutrient signaling in azole resistance. The vulnerability of Saccharomyces cerevisiae azole resistance phenotypes to perturbation was contingent upon specific auxotrophies. Using strains that acquired azole resistance by Erg3 loss of function as a model for resistance that depends on cellular stress responses, we delineated genetic and environmental factors that mitigate the translation of genotype into resistance phenotype. Compromising a global regulator that couples growth and metabolism to environmental cues, Tor kinase, provides a powerful strategy to abrogate drug resistance of S. cerevisiae and Candida albicans with broad therapeutic potential. (c) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 93
页数:13
相关论文
共 50 条
  • [31] Efflux-Mediated Antifungal Drug Resistance
    Cannon, Richard D.
    Lamping, Erwin
    Holmes, Ann R.
    Niimi, Kyoko
    Baret, Philippe V.
    Keniya, Mikhail V.
    Tanabe, Koichi
    Niimi, Masakazu
    Goffeau, Andre
    Monk, Brian C.
    CLINICAL MICROBIOLOGY REVIEWS, 2009, 22 (02) : 291 - +
  • [32] Antifungal Drug Resistance: An Emergent Health Threat
    Vitiello, Antonio
    Ferrara, Francesco
    Boccellino, Mariarosaria
    Ponzo, Annarita
    Cimmino, Carla
    Comberiati, Emilio
    Zovi, Andrea
    Clemente, Salvatore
    Sabbatucci, Michela
    BIOMEDICINES, 2023, 11 (04)
  • [33] Candida auris and Mechanisms of Antifungal Drug Resistance
    Alp, Sehnaz
    Akdagli, Sevtap Arikan
    MIKROBIYOLOJI BULTENI, 2021, 55 (01): : 99 - 112
  • [34] Evolution of antifungal drug resistance in Candida albicans
    Morschhaeuser, J.
    MYCOSES, 2014, 57 : 18 - 18
  • [35] Gene Expression and Evolution of Antifungal Drug Resistance
    Anderson, James B.
    Sirjusingh, Caroline
    Syed, Nazia
    Lafayette, Shantelle
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 1931 - 1936
  • [36] Antifungal drug resistance: not all azoles are equal
    Musaji, Naomi
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (05) : 515 - 516
  • [37] Mechanisms of antifungal drug resistance in Candida dubliniensis
    Coleman, David C.
    Moran, Gary P.
    McManus, Brenda A.
    Sullivan, Derek J.
    FUTURE MICROBIOLOGY, 2010, 5 (06) : 935 - 949
  • [38] Insights into the global emergence of antifungal drug resistance
    Boyce, Kylie
    Morrissey, Orla
    Idnurm, Alexander
    Macreadie, Ian
    MICROBIOLOGY AUSTRALIA, 2019, 40 (02) : 87 - 91
  • [39] Antifungal drug resistance of Trichophyton clinical isolates
    Monod, M.
    Fratti, M.
    Yamada, T.
    MEDICAL MYCOLOGY, 2018, 56 : S24 - S24
  • [40] Insights into the role of sphingolipids in antifungal drug resistance
    Kalra, Sapna
    Tanwar, Sunita
    Bari, Vinay Kumar
    FUNGAL BIOLOGY REVIEWS, 2024, 47